SNP | Genotype | Gender | p | Hip lesions | p | Clinical stages | p | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Male | Female | Unilateral | Bilateral | Stage II | Stage III | Stage IV | |||||
rs7408174 | CC | 8 | 6 | 0.775 | 5 | 9 | 0.285 | 3 | 5 | 6 | 0.694 |
CT | 42 | 35 | 18 | 59 | 19 | 39 | 19 | ||||
TT | 64 | 43 | 36 | 71 | 24 | 50 | 33 | ||||
rs34861192 | AA | 0 | 1 | 0.465 | 0 | 1 | 0.547 | 0 | 1 | 0 | 0.193 |
AG | 29 | 23 | 18 | 34 | 15 | 28 | 9 | ||||
GG | 86 | 60 | 41 | 105 | 32 | 65 | 49 | ||||
rs34124816 | AA | 94 | 77 | 0.105 | 51 | 120 | 0.650 | 41 | 78 | 52 | 0.557 |
CA | 20 | 6 | 8 | 18 | 6 | 14 | 6 | ||||
CC | 1 | 1 | 0 | 2 | 0 | 2 | 0 | ||||
rs3219175 | AA | 0 | 1 | 0.470 | 0 | 1 | 0.592 | 0 | 1 | 0 | 0.216 |
AG | 28 | 22 | 17 | 33 | 15 | 26 | 9 | ||||
GG | 86 | 60 | 41 | 105 | 31 | 66 | 49 | ||||
rs3745367 | AA | 12 | 9 | 0.775 | 3 | 18 | 0.263 | 3 | 14 | 4 | 0.049* |
AG | 48 | 39 | 27 | 60 | 24 | 44 | 19 | ||||
GG | 55 | 36 | 29 | 62 | 20 | 36 | 35 | ||||
rs3745368 | AA | 1 | 1 | 0.308 | 0 | 2 | 0.650 | 0 | 2 | 0 | 0.613 |
AG | 28 | 13 | 12 | 29 | 9 | 21 | 11 | ||||
GG | 86 | 70 | 47 | 109 | 38 | 71 | 47 | ||||
rs3745369 | CC | 8 | 6 | 0.876 | 4 | 10 | 0.059 | 2 | 11 | 1 | 0.161 |
CG | 50 | 40 | 20 | 70 | 20 | 41 | 29 | ||||
GG | 54 | 37 | 35 | 56 | 24 | 41 | 26 | ||||
rs1477341 | AA | 24 | 8 | 0.063 | 9 | 23 | 0.809 | 6 | 21 | 5 | 0.090 |
AT | 48 | 42 | 25 | 65 | 21 | 43 | 26 | ||||
TT | 35 | 33 | 22 | 46 | 17 | 25 | 26 |